KR101203096B1 - Producing method for fermented wild grass extracts with biological activity - Google Patents

Producing method for fermented wild grass extracts with biological activity Download PDF

Info

Publication number
KR101203096B1
KR101203096B1 KR1020120084841A KR20120084841A KR101203096B1 KR 101203096 B1 KR101203096 B1 KR 101203096B1 KR 1020120084841 A KR1020120084841 A KR 1020120084841A KR 20120084841 A KR20120084841 A KR 20120084841A KR 101203096 B1 KR101203096 B1 KR 101203096B1
Authority
KR
South Korea
Prior art keywords
fermented
extract
fermentation
lactic acid
pine needles
Prior art date
Application number
KR1020120084841A
Other languages
Korean (ko)
Inventor
이옥환
이영준
윤보라
이대원
김명동
Original Assignee
이대원
강원대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이대원, 강원대학교산학협력단 filed Critical 이대원
Priority to KR1020120084841A priority Critical patent/KR101203096B1/en
Application granted granted Critical
Publication of KR101203096B1 publication Critical patent/KR101203096B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Abstract

PURPOSE: A method for preparing fermented Artemisia princeps and pine needle extract is provided to reduce fat accumulation and to suppress ROS generation. CONSTITUTION: A method for preparing fermented medicinal herb extract comprises a step of inoculating lactic acid bacteria to Artemisia princeps and pine needle extract with the lactic acid bacteria and fermenting. The lactic acid bacteria are Leuconostoc mesenteroides 1076. The extract is prepared by pulverizing Artemisia princeps and pine needles, adding distilled water, and extracting at 24-26 Deg. C. for 23-25 hours. The method comprises: a step of pulverizing one of pine needles or Artemisia princeps; a step of adding water and extracting at 25 Deg. C. for 24 hours; a step of placing the extract at 0-4 Deg. C.; a step of inoculating Leuconostoc mesenteroides 1076 isolated from Kimchi; a step of fermenting at 30 Deg. C. and 200 rpm for 36 hours and centrifuging; a step of freeze-drying at 40 Deg. C. [Reference numerals] (AA) Selecting Artemisia princeps and pine needles; (BB) Washing and drying; (CC) Pulverizing (20-30 mesh); (DD) Incubating (0-4°C,24hr); (EE) Low temperature extraction (25°C,24hr); (FF) Adding 10 times of D.W; (GG) Inoculating strain into medicinal herb extract; (HH) Preculture of Leuconostoc mesenteroides 1076; (II) Selecting excellent strains with mannitol high productivity; (JJ) Fermentation process(30°C, 200rpm, 36 hr); (KK) Centrifuging(13,200 rpm); (LL) concentration at reduced pressure(40°C); (MM) Pulverizing; (NN) Freeze-drying

Description

생리활성을 갖는 발효 쑥 및 발효 솔잎 추출물의 제조 방법{Producing method for fermented wild grass extracts with biological activity}Producing method for fermented wild grass extracts with biological activity

본 발명은 발효 쑥 및 발효 솔잎 추출물의 제조방법에 관한 것으로, 젖산균을 이용하여 발효시켜 생리활성이 증진된 발효 쑥 및 발효 솔잎 추출물의 제조방법에 관한 것이다.
The present invention relates to a method for producing fermented mugwort and fermented pine needle extract, and relates to a method for producing fermented mugwort and fermented pine needle extract enhanced by physiological activity by fermentation using lactic acid bacteria.

국민소득 수준이 향상되면서 건강에 대한 소비자들의 관심이 커지고 웰빙 문화가 확산되어 이와 더불어 약용작물 수요도 늘고 있다. 이러한 변화는 농산물의 고품질화 및 브랜드화, 다양한 2?3차 산업부분과의 연계를 수단으로 하는 농산업의 외연 확장 추세 등과 맞물려, 약용작물의 수요가 증가하고 있다(출처: 한국농촌경제연구원, 약용작물 지역전략산업 육성방안, 2008).As the national income level improves, consumers' interest in health increases and the well-being culture spreads, and the demand for medicinal crops increases. This change, coupled with the high quality and branding of agricultural products and the trend of expansion of the agricultural industry by means of linkage with various secondary and tertiary industries, is increasing the demand for medicinal crops (Source: Korea Rural Economic Institute, Medicinal Crop Region). Strategic Industry Development Plan, 2008).

국내에서는 당귀, 천궁 등 60여 종의 약용작물이 재배되고 있는데 인삼을 제외한 우리나라 약용작물의 연간 생산액은 2006년 현재 5,635억 원으로 전체 농업생산액의 약 0.6%를 차지한다. 2007년 현재 재배 면적은 1만 1,433ha이고 생산량은 5만 6,764톤에 달한다. 현재, 시장 환경의 악화에 직면한 경종농가들이 작목을 전환하여 약용작물을 재배하는 경우도 많고, 재배기술이 개선됨으로써 생산성이 향상되고 있다(출처: 한국농촌경제연구원, 약용작물 지역전략산업 육성방안, 2008). In Korea, about 60 kinds of medicinal crops such as Dangui and Cheongung are cultivated. The annual output of medicinal crops in Korea, excluding ginseng, is 563 billion won, accounting for 0.6% of total agricultural production. As of 2007, the area of cultivation is 11,433 ha and the output is 59,764 tons. Currently, many farming farmers who face the deteriorating market environment are turning crops to cultivate medicinal crops, and productivity is improved by improving cultivation technology (Source: Korea Rural Economic Institute, Fostering Regional Strategic Industries for Medicinal Crops) , 2008).

이러한 약초는 대부분 설탕에 의한 발효공정을 통하여 판매되고 있는데 이러한 기존의 고당도 발효공정은 발효시 첨가되는 설탕의 농도가 높아 당뇨환자에게는 사용하지 못하는 단점이 있다. 그런데 소비자들의 약초 선택 기준에 대한 설문조사에서 따르면, 소비자들은 약초의 기능성만큼이나 품질과 맛에 가장 중점을 둔다고 답하였다. 이에 제품의 품질과 저장성을 유지하면서 고당도를 대체할 감미료를 사용할 필요성이 제기되고 있다. Most of these herbs are sold through a fermentation process using sugar, but the existing high sugar fermentation process has a disadvantage in that it cannot be used for diabetic patients due to the high concentration of sugar added during fermentation. However, according to a survey of consumers' selection criteria, consumers replied that the emphasis was on quality and taste as much as the functionality of herbs. Therefore, there is a need to use sweeteners to replace high sugar content while maintaining product quality and shelf life.

또한, 기존의 고당도 발효공정은 자연발효법을 이용하여 발효기간이 길고, 유효성분의 추출공정 최적화가 어려우며 이에 따른 생리활성(항산화, 항비만 효과 등)의 증대도 기대하기 어렵다는 문제점도 있다. 이에 제품의 기능성까지 증진시킬 수 있는 발효공정을 최적화할 필요성이 제기되어 있다. In addition, the existing high sugar fermentation process has a long fermentation period using the natural fermentation method, it is difficult to optimize the extraction process of the active ingredient and there is also a problem that it is difficult to expect the increase in the physiological activity (antioxidant, anti-obesity effect, etc.). Therefore, there is a need to optimize the fermentation process that can improve the functionality of the product.

한편, 한국의 전통발효식품인 김치는 젖산균의 이형발효를 통하여 젖산 이외의 초산, 에탄올, 탄산가스, 만니톨 등이 생성되는데, 이 중 만니톨은 김치의 숙성을 지연시켜 시어지는 것을 방지하고 시원한 청량감을 주는 것으로 알려져 있다.On the other hand, Kimchi, a traditional Korean fermented food, produces acetic acid, ethanol, carbon dioxide, and mannitol other than lactic acid through heterogeneous fermentation of lactic acid bacteria, among which mannitol prevents aging of kimchi and prevents it from being soaked. It is known to give.

만니톨은 6 탄소 당 알콜의 일종으로 설탕의 30~40% 정도의 감미도를 가지고 있어 설탕의 사용이 제한되는 식품 제조에서 대용 감미료로 사용되고 있으며, 저열량, 냉음미, 저흡습성 등의 특성을 갖고 있어 껌, 캔디 등의 제과류의 첨가제로 많이 이용되고 있다(출처: 한국생물공학회, Leuconostoc mesenteroides NRRL B-1149를 이용한 Mannitol 생산, 2002).Mannitol is a kind of 6-carbon sugar alcohol, which has a sweetness of about 30-40% of sugar, and is used as a substitute sweetener in food production where the use of sugar is limited.It has properties such as low calorie, cold taste, and low hygroscopicity. It is widely used as an additive in confectionery such as candy and candy (Source: Korea Biotechnology Association, Leuconostoc Mannitol production using mesenteroides NRRL B-1149, 2002).

이에 본원발명의 발명자들은 전통적으로 식품발효에 이용되어 온 김치에서 분리된 젖산균을 이용하여 약초를 발효함으로써, 만니톨 생성에 의한 관능성과 보존성을 향상시키고, 기능성까지 대폭 증진시키고자 한 것이다. Accordingly, the inventors of the present invention intend to ferment herbs using lactic acid bacteria isolated from kimchi which has been traditionally used for food fermentation, thereby improving the functionality and preservation by mannitol production and greatly improving the functionality.

한국 등록특허 제10-0353481호(솔잎발효음료 및 그의 제조법)에는 세절한 솔잎, 솔순 또는 잣잎에 흰설탕, 황설탕, 흑설탕, 꿀 및 물엿 중에서 선택된 감미료와 물을 솔잎, 솔순 또는 잣잎의 중량을 기준으로 1 ~ 1.2 : 19 ~ 21의 중량비로 혼합하여 끓여서 식힌 감미료 수용액을 붓고 20 ± 1℃에서 5 일간 자연발효시킨 후 여과 및 캔 포장하여 살균시키는 단계를 포함하여 이루어지는 발효음료의 제조방법이 개시되었는데, 이는 솔잎의 자연발효에 관한 것으로 본 발명과는 차이가 있다.Korean Registered Patent No. 10-0353481 (pine needle fermented beverage and its manufacturing method) is a fine pine needles, pine needles or pine needles and the sweetener and water selected from white sugar, yellow sugar, brown sugar, honey and starch syrup to the weight of pine needles, pine needles or pine needles Disclosed is a method for preparing a fermented beverage, comprising the step of pouring a boiled and cooled sweetener solution by mixing in a weight ratio of 1 to 1.2: 19 to 21 and naturally fermenting at 20 ± 1 ° C. for 5 days, followed by filtration and can packaging for sterilization. This is related to the natural fermentation of pine needles is different from the present invention. 한국 등록특허 제1000412425호(숙취해소 효과가 있는 솔잎의 다단발효추출물)에는 솔잎을 물, 당과 혼합하여 자연발효시키는 제 1차 발효 단계와; 상기 제 1차 발효 단계에서 수득한 발효액과 솔잎의 발효 잔여물을 분리하는 단계와; 상기 솔잎의 발효 잔여물을 솔잎과 혼합하여 열추출한 다음 감압 농축하여 농축추출액을 얻는 단계와; 상기 발효액과 상기 농축추출액을 혼합하여 재발효시키는 제 2차 발효 단계와; 상기 제 2차 발효 단계에서 발효된 혼합액을 혐기적 환경에서 숙성하는 단계를 포함하는 방법에 의해 제조되는 솔잎의 다단발효추출물을 유효성분으로 포함하는 숙취해소용 기능성 식음료가 개시되었는데, 이는 다단발효에 관한 것으로 본 발명과는 차이가 있다.Korean Patent No. 1000412425 (Multi-stage fermentation extract of pine needles having a hangover effect) includes a first fermentation step of naturally fermenting pine needles with water and sugar; Separating the fermentation broth from the fermentation broth obtained from the first fermentation step and pine needles; Mixing the fermentation residues of the pine needles with pine needles and extracting them by heat, then concentrating under reduced pressure to obtain a concentrated extract; A second fermentation step of mixing and fermenting the fermentation broth and the concentrated extract solution; A functional food and beverage for hangover elimination comprising a multi-stage fermentation extract of pine needles prepared by the method comprising the step of aging the mixed solution fermented in the second fermentation step in an anaerobic environment as an active ingredient, which is a multi-stage fermentation The present invention is different from the present invention.

본 발명은 상기 종래기술의 문제점을 해결하기 위하여 약초 발효시 설탕 등을 사용하지 않아도 기호도를 높게 유지시킬 수 있는 발효 약초 추출물의 제조방법을 제공하고자 한다. The present invention is to provide a method for producing a fermented herbal extract that can maintain a high degree of preference even without using sugar when fermenting herbs in order to solve the problems of the prior art.

또한, 본 발명은 페놀성 화합물이 다량 함유되어 있어 항산화능이 대폭 증진된 발효 약초 추출물의 제조방법을 제공하고자 한다. In addition, the present invention is to provide a method for producing a fermented herbal extract with a large amount of phenolic compound is significantly enhanced antioxidant capacity.

또한, 본 발명은 지방축적을 탁월하게 감소시키고 ROS 생성을 탁월하게 억제하여 항비만 효과가 탁월한 발효 약초 추출물의 제조방법을 제공하고자 한다.
In addition, the present invention is to provide a method for producing a fermented herbal extract excellent in anti-obesity effect by excellently reducing fat accumulation and inhibiting ROS production.

상기 목적을 달성하기 위하여, 본 발명은 쑥 또는 솔잎 중 하나 이상의 추출물에 젖산균을 접종하여 발효시키는 것을 특징으로 발효 약초 추출물의 제조방법을 제공한다. In order to achieve the above object, the present invention provides a method for producing a fermented herbal extract, characterized in that the fermentation by inoculating lactic acid bacteria in one or more extracts of mugwort or pine needles.

또한, 본 발명은 상기 젖산균이 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076인 것을 특징으로 하는 발효 약초 추출물의 제조방법을 제공한다. The present invention also provides a method for producing a fermented herbal extract, characterized in that the lactic acid bacteria is Leuconostoc mesenteroides 1076.

또한, 본 발명은 상기 쑥 또는 솔잎 중 하나 이상의 추출물이 쑥 또는 솔잎 중 하나 이상을 분쇄한 후, 증류수를 가하여 24 ~ 26℃에서 23 ~ 25시간 동안 추출한 것을 특징으로 하는 발효 약초 추출물의 제조방법을 제공한다. In addition, the present invention after the one or more extracts of the mugwort or pine needles pulverized one or more of the mugwort or pine needles, the method of producing a fermented herbal extract characterized in that the extract for 23 to 25 hours at 24 ~ 26 ℃ by adding distilled water to provide.

또한, 본 발명은 상기 발효가 190 ~ 210 rpm으로 29 ~ 31℃에서 35 ~ 37 시간 동안 수행되는 것을 특징으로 하는 발효 약초 추출물의 제조방법을 제공한다.
In addition, the present invention provides a method for producing a fermented herbal extract, characterized in that the fermentation is carried out for 35 to 37 hours at 29 ~ 31 ℃ at 190 ~ 210 rpm.

본 발명은 발효 약초 추출물의 제조방법에 관한 것으로, 쑥 또는 솔잎 중 하나 이상의 추출물에 젖산균을 접종하여 발효시키는 것을 특징으로 한다. 이와 같이 본 발명은 쑥 또는 솔잎 중 하나 이상을 종래의 자연발효법이 아닌 젖산균을 이용하여 발효시킴에 따라 발효시간이 대폭 단축되어 공정상 이점이 있고, 생리활성성분이 대폭 증가하여 항산화, 항비만 활성과 같은 여러 생리활성이 탁월하게 증진된다.The present invention relates to a method for producing a fermented herbal extract, characterized in that the fermentation by inoculating lactic acid bacteria to one or more extracts of mugwort or pine needles. As such, the present invention has a process advantage by significantly shortening the fermentation time by fermenting one or more of the mugwort or pine needles using lactic acid bacteria rather than the conventional natural fermentation method. Many physiological activities such as are greatly enhanced.

여기서, 상기 젖산균은 김치 유래 젖산균인 것이 바람직하고, 가장 바람직하게는 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076이다. 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076은 만니톨 생산성이 매우 우수하여, 이를 이용하여 쑥 또는 솔잎 중 하나 이상의 추출물을 발효시키는 경우 설탕을 첨가하지 않고 발효시켜도 단맛이 적절하게 나서 관능적 특성이 매우 우수한 발효 추출물을 제조할 수 있다. Here, the lactic acid bacteria is preferably lactic acid bacteria derived from kimchi, most preferably Leuconostoc ( Leuconostoc) mesenteroides ) 1076. Leuconostoc mesenteroides ) 1076 is very excellent in mannitol productivity, when using the fermentation of one or more extracts of mugwort or pine needles can be prepared fermentation extract having a very good sweet taste even after fermentation without adding sugar is very good.

이때, 발효는 190 ~ 210 rpm으로 29 ~ 31℃에서 35 ~ 37 시간 동안 수행되는 것이 바람직하다. 상기 조건을 만족하는 경우 만니톨이 다량 생성되어 그 맛이 매우 우수하고, 페놀성 화합물도 다량 생성되어 항산화, 항비만 등 각종 생리활성이 매우 우수한 발효 추출물을 제조할 수 있다. At this time, the fermentation is preferably carried out for 35 to 37 hours at 29 ~ 31 ℃ at 190 ~ 210 rpm. If the above conditions are satisfied, a large amount of mannitol is produced, and the taste is very good, and a large amount of phenolic compounds are also produced, and thus, fermentation extracts having excellent physiological activities such as antioxidant and anti-obesity can be prepared.

또한, 여기서 쑥 또는 솔잎 중 하나 이상의 추출물은 쑥 또는 솔잎 중 하나 이상을 분쇄한 후, 증류수를 가하여 24 ~ 26℃에서 23 ~ 25시간 동안 추출한 것이 바람직한데, 이와 같이 저온추출을 함에 따라 여러 생리활성성분이 파괴되지 않는다는 이점이 있다. In addition, the extract of one or more of the mugwort or pine needles is preferably pulverized one or more of the mugwort or pine needles, and then extracted for 23 to 25 hours at 24 ~ 26 ℃ by adding distilled water, so as to extract various physiological activity There is an advantage that the components are not destroyed.

바람직하게는 본 발명은 솔잎 또는 쑥 중 하나 이상을 조분쇄한 후, 10배의 물을 첨가하여 저온 추출(25℃, 24시간)하여 0 ~ 4℃에서 정치한 후, 김치로부터 분리한 만니톨 생성능이 우수한 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076을 접종하여 200 rpm으로 30℃에서 36시간 발효한 후, 원심분리(13,200 rpm)하고 감압농축(40℃)하여 동결건조함으로써, 생리활성이 대폭 증진된 발효 추출물을 수득할 수 있다. Preferably, the present invention is coarsely pulverized at least one of pine needles or wormwood, and then extracted with low temperature (25 ℃, 24 hours) by adding 10 times of water and left at 0 ~ 4 ℃, mannitol production ability separated from kimchi Inoculated with this excellent Leuconostoc mesenteroides 1076 and fermented at 200 rpm for 30 hours at 30 ℃, centrifugation (13,200 rpm) and concentrated under reduced pressure (40 ℃) by lyophilization, greatly physiological activity Enhanced fermentation extracts can be obtained.

이와 같이 수득된 본 발명의 발효 추출물은 종래의 설탕에 의한 발효공정을 거친 약초 발효액에 비하여 페놀성 화합물의 함량이 대략 11.5배(발효 솔잎 추출물), 27.5배(발효 쑥 추출물) 증가하였으며, 이에 따라 항산화 및 항비만 활성도 종래의 약초 발효액에 비하여 탁월하게 증진되었다. Thus obtained fermented extract of the present invention increased the content of the phenolic compound by approximately 11.5 times (fermented pine needle extract), 27.5 times (fermented mugwort extract) compared to the conventional herbal fermentation broth with sugar, accordingly Antioxidant and anti-obesity activities have also been enhanced compared to conventional herbal fermentation broths.

비만은 비정상적인 지방세포(adipocyte)의 크기 및 숫자의 증가로 생체내의 지방조직이 과도하게 축적된 상태를 의미하며, 지방세포 숫자의 증가는 전지방세포(preadipocyte)의 활발한 증식과 이들의 활성화된 지방세포 분화(adipogensis)과정으로 인해 발생한다. 현재 adipogenesis에 대한 유전자 수준에서의 연구는 여러 세포주를 이용하여 연구되어 왔으며 murine C3H10T1/2 배아세포, 3T3-F442A 및 3T3-L1은 지방세포의 분화와 기능연구에 대표적인 in vitro model로 사용된다.Obesity is an abnormal accumulation of fat tissue in the body due to abnormal increase in the size and number of adipocytes, the increase in the number of adipocytes is the active proliferation of preadipocytes and their activated fat It is caused by the process of adipogensis. Currently, gene-level studies on adipogenesis have been studied using several cell lines, and murine C3H10T1 / 2 embryonic cells, 3T3-F442A and 3T3-L1, are used as representative in vitro models for the study of differentiation and function of adipocytes.

3T3-L1 지방세포의 경우, 전구지방세포(preadipocyte)가 지방세포로 분화되는 과정 중에 지방의 축적(fat accumulation) 및 활성산소종(reactive oxygen species, ROS)의 생성이 급격하게 증가하게 되는데 과도하게 생성된 활성산소종은 인슐린 저항성 및 여러 대사증후군의 원인으로 밝혀지고 있다. In the case of 3T3-L1 adipocytes, fat accumulation and reactive oxygen species (ROS) production increase rapidly during the process of preadipocyte differentiation into adipocytes. The resulting reactive oxygen species has been found to be the cause of insulin resistance and several metabolic syndromes.

그런데, 본 발명의 발효 추출물은 지방 축적 억제 효과와 ROS 생성 저감 효과가 매우 탁월하여 대사증후군 관련 기능성 소재로 효과적으로 이용될 수 있으며, 바람직하게는 항산화용 또는 항비만용 기능성 식품 조성물로 이용될 수 있다. However, the fermented extract of the present invention is very excellent in inhibiting fat accumulation and reducing ROS production, and thus may be effectively used as a functional material related to metabolic syndrome. Preferably, the fermented extract may be used as an antioxidant or anti-obesity functional food composition. .

게다가 본 발명의 발효 추출물은 만니톨 생성 우수 균주인 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076을 이용하여 발효시킴에 따라 설탕 등을 첨가하지 않고 발효시켜도 단맛이 적절하게 유지되는 동시에 발효 취, 쓴맛, 떫은맛은 대폭 감소되어 소비자의 기호도도 매우 높다.
Furthermore, the fermentation extract of the present invention is fermented using Leuconostoc mesenteroides 1076, which is an excellent strain of mannitol production, so that even when fermented without adding sugar, fermentation odor, bitter taste, The astringent taste is greatly reduced, and consumer preference is very high.

본 발명에 의하면 설탕 등을 첨가하지 않아도 단맛이 유지되어 기호도가 높은 발효 약초 추출물을 제공할 수 있다. According to the present invention it is possible to provide a fermented medicinal herb extract with high preference even if sugar is not added.

또한, 본 발명에 의하면 페놀성 화합물의 함량이 매우 높아 항산화, 항비만 효과가 매우 탁월한 발효 약초 추출물을 제공할 수 있다. In addition, according to the present invention it is possible to provide a fermented medicinal herb extract having a very high content of a phenolic compound and having excellent antioxidant and anti-obesity effects.

또한, 본 발명에 의하여 단기간의 발효로도 항산화, 항비만 효과가 매우 높은 발효 약초 추출물을 제공할 수 있다.
In addition, the present invention can provide a fermented herbal extract with a very high anti-oxidation and anti-obesity effect even with short-term fermentation.

도 1은 Lactobacillus 속 젖산균 (19종)의 만니톨 생성량을 나타낸다.
도 2는 Leuconostoc 속 젖산균 (27종)의 만니톨 생성량을 나타낸다.
도 3은 Weissella 속 젖산균 (5종)의 만니톨 생성량을 나타낸다.
도 4는 Lactobacillus 속 젖산균 (19종)의 만니톨 생산 수율을 나타낸다.
도 5는 Leuconostoc 속 젖산균 (27종)의 만니톨 생산 수율을 나타낸다.
도 6은 Weissella 속 젖산균 (5종)의 만니톨 생산 수율을 나타낸다.
도 7은 Lactobacillus 속 젖산균 (19종)의 만니톨 생산성을 나타낸다.
도 8은 Leuconostoc 속 젖산균 (19종)의 만니톨 생산성을 나타낸다.
도 9는Weissella 속 젖산균 (5종)의 만니톨 생산성을 나타낸다.
도 10은 Lactic acid 농도 별 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076의 비성장속도를 나타낸다.
도 11은 Acetic acid 농도 별 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076의 비성장속도를 나타낸다.
도 12는 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 총 페놀 함량을 나타낸다.
도 13은 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 총 플라보노이드 함량을 나타낸다.
도 14는 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 DPPH 라디칼 소거능을 나타낸다.
도 15는 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 ABTS 라디칼 소거능을 나타낸다.
도 16은 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 FRAP 활성을 나타낸다.
도 17은 산야초 발효액, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물의 환원력(Reducing Power)을 나타낸다.
도 18은 XTT assay를 통한 시료의 세포 독성 측정 결과를 나타내다.
도 19는 ORO staining을 통한 지방 축적 억제 효과 측정 결과를 나타낸다.
도 20은 NBT assay를 통한 ROS 생성 억제 효과 측정 결과를 나타낸다.
도 21은 발효 쑥 추출물 및 발효 솔잎 추출물의 지방 축적 억제 및 ROS 생성 저감 효과를 나타낸다.
도 22는 발효 쑥 및 발효 솔잎 추출물의 관능적 특성을 나타낸다.
도 23은 본 발명의 발효 솔잎 추출물, 발효 쑥 추출물의 제조 공정도이다.
1,Lactobacillus The production amount of mannitol of the genus Lactic acid bacteria (19 species) is shown.
2 isLeuconostoc The production amount of mannitol of the genus Lactic acid bacteria (27 species) is shown.
3 isWeissella The production amount of mannitol of the genus Lactic acid bacteria (5 types) is shown.
4 isLactobacillus The yield of mannitol production of the genus Lactic acid bacteria (19 species) is shown.
5 isLeuconostoc The yield of mannitol production of the genus Lactic acid bacteria (27 species) is shown.
6 isWeissella The yield of mannitol production of the genus Lactic acid bacteria (5 species) is shown.
7 isLactobacillus Mannitol productivity of the genus Lactic acid bacteria (19 species) is shown.
8 isLeuconostoc Mannitol productivity of the genus Lactic acid bacteria (19 species) is shown.
9 isWeissella Mannitol productivity of the genus Lactic acid bacteria (5 types) is shown.
10 is leukonostock mesenteroides by Lactic acid concentration (Leuconostoc mesenteroides) Shows a specific growth rate of 1076.
Figure 11 shows the leukonostock mesenteroides for each acetic acid concentration (Leuconostoc mesenteroides) Shows a specific growth rate of 1076.
Figure 12 shows the total phenolic content of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 13 shows the total flavonoid content of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 14 shows the DPPH radical scavenging ability of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 15 shows the ABTS radical scavenging ability of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 16 shows the FRAP activity of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 17 shows the reducing power (Reducing Power) of wild vinegar fermentation broth, fermented mugwort extract, fermented pine needle extract and mixed fermented extract.
Figure 18 shows the cytotoxicity measurement results of the sample through the XTT assay.
Figure 19 shows the result of measuring the fat accumulation inhibitory effect through ORO staining.
20 shows the results of measuring the inhibition of ROS production through NBT assay.
21 shows the effect of inhibiting fat accumulation and reducing ROS production of fermented mugwort extract and fermented pine needle extract.
Figure 22 shows the sensory characteristics of fermented mugwort and fermented pine needle extract.
Figure 23 is a production process of the fermented pine needle extract, fermented mugwort extract of the present invention.

이하, 본 발명의 내용을 하기 실시예를 들어 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the scope of the present invention is not limited to the following embodiments, and includes modifications of equivalent technical ideas.

실험예Experimental Example 1 :  One : 만니톨Mannitol 생산성 우수 균주의 선별 Selection of strains with high productivity

만니톨 생산성이 우수한 균주를 선별하기 위하여 김치 유래 젖산균 51 종 (Latobacillus 속 19종, Leuconostoc 속 27종, Weissella 속 5종)을 실험에 사용하였다. 김치유래 젖산균들은 한국미생물 자원센터로부터 분양 및 실험실 보유 균주를 이용하였다. 2% glucose MRS (BD, USA) 배지에서 전배양한 젖산균을 멸균수로 2회 세척 후, 5% fructose MRS (BD, USA) 배지에 초기 농도 (OD600) 0.05로 접종하여 24시간 동안 진탕배양 (30 , 200 rpm)하였다. MRS (5% fructose) 접종 초기와 24시간 배양 후 1 mL씩 회수하여 상등액을 확보하였으며, 만니톨 어세이 키트(Megazyme, Ireland)를 이용하여 만니톨 생산량을 측정하였다.In order to select strains with high mannitol productivity, 51 kimchi-derived lactic acid bacteria (19 species of Latobacillus , 27 species of Leuconostoc , and 5 species of Weissella ) were used in the experiment. Kimchi-derived lactic acid bacteria were used by the Korea Microbial Resources Center for preservation and laboratory strains. Lactobacillus pre-cultured in 2% glucose MRS (BD, USA) medium was washed twice with sterile water, and then inoculated at 5% fructose MRS (BD, USA) medium at an initial concentration of 0.05 (OD 600 ) of 0.05 for 24 hours. (30, 200 rpm). The supernatant was obtained by recovering 1 mL of MRS (5% fructose) inoculation and after 24 hours of incubation, and mannitol production was measured using a mannitol assay kit (Megazyme, Ireland).

그 결과는 도 1 내지 9에 나타내었다. 총 51종의 젖산균 스크리닝을 통해 만니톨의 생성량과 수율, 생산성을 비교한 결과, 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076이 만니톨 생산성이 가장 우수함을 알 수 있었다.
The results are shown in FIGS. 1 to 9. A total of 51 lactic acid bacteria screenings were performed to compare the production, yield, and productivity of mannitol, showing the results of Leuconostoc. mesenteroides ) 1076 showed the highest mannitol productivity.

실험예Experimental Example 2 : 류코노스톡  2: Leukono Stock 메센테로이데스Mecenteroides (( LeuconostocLeuconostoc mesenteroidesmesenteroides )) 1076의 내삼투압성 검증Osmosis Resistance Verification of 1076

젖산균은 배양시 생성되는 acetic acid와 lactic acid에 의해서 생육이 저해되므로 내삼투압성을 측정하여 이러한 부산물에 대한 내성을 확인하고자 하였다. Since lactic acid bacteria were inhibited by acetic acid and lactic acid produced during the culture, the resistance to these by-products was determined by measuring the osmotic resistance.

Lactic acid를 1, 2, 3, 4, 5, 6, 10 g/L로 함유한 배지에서 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076을 배양한 결과를 도 10에 나타내었는데, 농도 유의적으로 L. mesenteroides의 비성장속도가 감소함을 확인할 수 있었다. Leuconostoc in a medium containing lactic acid at 1, 2, 3, 4, 5, 6, 10 g / L mesenteroides ) 1076 was shown in Figure 10, it was confirmed that the specific growth rate of L. mesenteroides significantly decreased.

Acetic acid를 1, 2, 3, 4, 5, 6, 10 g/L로 함유한 배지에서 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076을 배양한 결과는 도 11에 나타내었는데, 농도 유의적으로 L. mesenteroides의 비성장속도가 감소함을 확인할 수 있었다. Leuconostoc in a medium containing 1, 2, 3, 4, 5, 6, 10 g / L of Acetic acid mesenteroides ) 1076 was shown in Figure 11, it was confirmed that the specific growth rate of L. mesenteroides significantly decreased.

이에 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076의 내삼투압성을 확인할 수 있었다.
Leuconostoc mesenteroides ) 1076 was able to confirm the osmotic resistance.

제조예Manufacturing example 1 : 발효 솔잎 추출물의 제조 1: Preparation of Fermented Pine Needle Extract

조분쇄된 솔잎 분말에 각각 10배의 증류수를 첨가하고 25℃에서 24시간 교반하면서 저온 추출한 후, 만니톨(mannitol) 고생산성 균주인 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076을 MRS(2% glucose) 배지에서 전배양 후 상기 솔잎 추출물 1L에서 30℃, 200 rpm으로 36시간 동안 배양하였다. 발효된 솔잎 추출물은 감압농축 및 동결건조 하여 분말화하였다.
10 times distilled water was added to the coarsely pulverized pine needle powder, followed by low temperature extraction with stirring at 25 ° C. for 24 hours, followed by Leuconostoc , a highly mannitol high-productive strain, Leuconostoc. mesenteroides ) 1076 was precultured in MRS (2% glucose) medium, and then cultured for 36 hours at 30 ° C. and 200 rpm in 1 L of the pine needle extract. Fermented pine needle extract was concentrated under reduced pressure and lyophilized to powder.

제조예Manufacturing example 2 : 발효 쑥 추출물의 제조 2: Preparation of Fermented Mugwort Extract

솔잎 대신 쑥을 사용한 것을 제외하고는 상기 제조예 1과 동일한 방식으로 발효된 쑥 추출물을 제조하였다.
Mugwort extract fermented in the same manner as in Preparation Example 1 was prepared except that instead of using pine needles.

제조예Manufacturing example 3 : 발효 혼합 추출물의 제조 3: Preparation of Fermented Mixed Extract

상기 제조예 1, 2의 발효 쑥잎 추출물과 발효 쑥 추출물을 동량으로 혼합한 혼합 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w)을 제조하였다.
A mixed extract (fermented pine needles: fermented mugwort = 1: 1, w / w) of the same amount of fermented mugwort leaf extract and fermented mugwort extract of Preparation Examples 1 and 2 was prepared.

비교 compare 제조예Manufacturing example : 산야초 발효액의 제조 : Manufacture of Sanyacho Fermentation Broth

산야초(솔잎, 쑥, 쇠비름 등)의 전초를 세척한 후 항아리에 담아 설탕을 첨가하고 상온에서 180일간 숙성시킨 후, 산야초 숙성액을 거름망에 여과하여 다시 180일 이상 자연발효시켜 산야초 발효액을 제조하였다.
After washing the outposts of wild vinegar (pine needles, mugwort, purslane, etc.), put them in a jar, add sugar, and ripen them at room temperature for 180 days, and then fermented wild vinegar by filtering the wild vinegar fermentation broth for more than 180 days. .

실험예Experimental Example 3 : 발효 쑥 추출물 및 발효 솔잎 추출물의 유용성분 분석 3: Analysis of Useful Components of Fermented Mugwort Extract and Fermented Pine Needle Extract

< 총 페놀 함량 ><Total Phenolic Content>

각 시료를 1 mg/mL의 농도로 제조한 후 시료를 15 mL튜브에 1 mL씩 첨가하였다. 그 후 10% Folin 시약과 10% Na2CO3 1 mL를 첨가하였다. 1시간 동안 반응시킨 후 96-well plate에 200 ㎕씩 옮겨 흡광도 750 nm에서 측정하였다. Each sample was prepared at a concentration of 1 mg / mL and then 1 mL of the sample was added to a 15 mL tube. Then 10% Folin reagent and 1 mL of 10% Na 2 CO 3 were added. After reacting for 1 hour, 200 μl was transferred to a 96-well plate and the absorbance was measured at 750 nm.

그 결과는 도 12에 나타내었는데, 발효 솔잎 추출물에서는 116.30±4.58 GAE mg/g, 발효 쑥 추출물에서는 181.63±3.51 GAE mg/g, 발효 혼합 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w)에서는 158.30±3.00 GAE mg/g 값이 나와 산야초 발효액에 비하여 총 페놀 함량이 매우 높은 것으로 나타났다.
The results are shown in Figure 12, 116.30 ± 4.58 GAE mg / g in fermented pine needle extract, 181.63 ± 3.51 GAE mg / g in fermented mugwort extract, fermented mixed extract (fermented pine needles: fermented mugwort = 1: 1, w / w ) Shows 158.30 ± 3.00 GAE mg / g, which is higher in total phenolic content than wild vinegar fermentation broth.

< 총 플라보노이드 함량 ><Total Flavonoid Content>

총 플라보노이드 함량은 각 시료별로 1 mg/mL의 농도로 제작한 후 시료를 15 mL 튜브에 0.5 mL씩 첨가하였다. 그 후 에탄올 95%를 1.5 mL, 10% aluminum nitrate 0.1 mL, 1 M potassium acetate 0.1 mL, 증류수 2.8 mL 첨가 후 상온에서 30분간 방치하였다. 상온에서 30분간 반응시킨 96-well plate에 200 ㎕씩 옮겨 흡광도 415 nm에서 측정하였다. The total flavonoid content was prepared at a concentration of 1 mg / mL for each sample, and 0.5 mL of the sample was added to a 15 mL tube. After ethanol 95% was added 1.5 mL, 10% aluminum nitrate 0.1 mL, 1 M potassium acetate 0.1 mL, distilled water 2.8 mL and left at room temperature for 30 minutes. The absorbance was transferred to a 96-well plate reacted for 30 minutes at room temperature 200 ㎕ measured at 415 nm.

그 결과는 도 13에 나타내었는데, 발효 솔잎 추출물에서는 87.90±3.68 NE mg/g, 발효 쑥 추출물에서는 145.13±16.88 NE mg/g, 발효 혼합 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w)에서는 115.04±15.42 NE mg/g 값이 측정되어 산야초 발효액에 비하여 총 플라보노이드 함량이 매우 높은 것으로 나타났다.
The results are shown in Figure 13, 87.90 ± 3.68 NE mg / g in fermented pine needle extract, 145.13 ± 16.88 NE mg / g in fermented mugwort extract, fermented mixed extract (fermented pine needles: fermented mugwort = 1: 1, w / w ), 115.04 ± 15.42 NE mg / g was measured, indicating that the total flavonoid content was higher than that of wild vinegar fermentation broth.

< 발효 쑥 또는 발효 솔잎 추출물, 산야초 발효액의 개별 페놀성 화합물의 함량 ><Contents of Individual Phenolic Compounds from Fermented Mugwort or Fermented Pine Needle Extract and Wild Vegetable Fermentation Solution>

상기 제조예 1, 2의 발효 솔잎, 발효 쑥 추출물, 비교 제조예의 산야초 발효액에 함유된 개별 페놀성 화합물의 함량을 분석하였다. The contents of the individual phenolic compounds contained in the fermented pine needles, fermented mugwort extracts of Preparation Examples 1 and 2, and the Sanyacho fermentation broth of Comparative Preparation Example were analyzed.

HPLC 시스템은 Shimadzu 모델 (Shimadzu-Model No. SPD-M10A VP, Kyoto, Japan)을 사용하였고, Agilent C18 column (15 cm × 4.6 mm, 5 ㎛, Agilent Technologies, Santa Clara, CA, USA)로 분리된 성분들은 diode-array 검출기로 분석하였다. 이동상은 2 mM sodium acetate를 함유한 6% acetic acid (final pH 2.55, v/v, solvent A)와 acetonitrile (solvent B)를 사용하였고 flow rate는 1.0 mL/min이었다. 총 80분간 분석하면서 용매의 조성은 gradient 프로그램으로 0 ~ 15% B (45 min), 15 ~ 30% B (15 min), 30 ~ 50% B (5 min), 50 ~ 100% B (5 min) 및 100 ~ 0% B (10 min)의 조건으로 injection volume은 10 ㎕하여 분석하였다. 분석에 사용된 표준물질은 4-hydroxyl benehydrazid, coumarin, garlic acid, pyrogallol, catechin, vanillic acid, chlorogenic acid, caffeic acid, p-comaric acid, p-anisic acid, coumarin, rutin, quercitrin hydrate, myricetin, qucetein, ruteorin, hesperetin, dexamethasone, alizarin, 및 rhein를 이용하였다.The HPLC system used a Shimadzu model (Shimadzu-Model No. SPD-M10A VP, Kyoto, Japan), separated by an Agilent C18 column (15 cm × 4.6 mm, 5 μm, Agilent Technologies, Santa Clara, CA, USA). The components were analyzed with a diode-array detector. The mobile phase consisted of 6% acetic acid (final pH 2.55, v / v, solvent A) and acetonitrile (solvent B) containing 2 mM sodium acetate, and the flow rate was 1.0 mL / min. The composition of the solvent was analyzed for a total of 80 minutes. The composition of the solvent was 0 to 15% B (45 min), 15 to 30% B (15 min), 30 to 50% B (5 min), 50 to 100% B (5 min). ) And 100 ~ 0% B (10 min) injection volume was analyzed by 10 μl. Standards used in the analysis were 4-hydroxyl benehydrazid, coumarin, garlic acid, pyrogallol, catechin, vanillic acid, chlorogenic acid, caffeic acid, p-comaric acid, p-anisic acid, coumarin, rutin, quercitrin hydrate, myricetin, qucetein , ruteorin, hesperetin, dexamethasone, alizarin, and rhein were used.

NameName Retention time
(min)
Retention time
(min)
ug/g 추출물ug / g extract
제조예 1Production Example 1 제조예 2Production Example 2 비교 제조예Comparative Production Example 4-hydroxyl benehydrazid4-hydroxyl benehydrazid 2.782.78 -1) -1) 1,715.84 1,715.84 -  - coumarincoumarin 2.822.82 -  - -  - 59.72 59.72 garlic acidgarlic acid 3.043.04 0.10 0.10 11.57 11.57 84.41 84.41 pyrogallolpyrogallol 3.463.46 -  - 2,324.89 2,324.89 414.01 414.01 catechincatechin 11.2211.22 0.97 0.97 -  - 204.28 204.28 vanillic acidvanillic acid 16.5116.51 -  - 3,390.04 3,390.04 79.35 79.35 chlorogenic acidchlorogenic acid 16.7516.75 6,828.22 6,828.22 -  - -  - caffeic acidcaffeic acid 17.6217.62 -  - 0.45 0.45 -  - p-comaric acidp-comaric acid 28.3028.30 -  - 9.86 9.86 -  - p-anisic acidp-anisic acid 40.9740.97 535.16 535.16 669.72 669.72 -  - coumarincoumarin 42.5542.55 753.53 753.53 -  - -  - rutinrutin 47.3647.36 4,002.70 4,002.70 10,789.58 10,789.58 -  - quercitrin hydratequercitrin hydrate 53.9853.98 202.25 202.25 345.80 345.80 -  - myricetinmyricetin 54.3254.32 -  - 617.76 617.76 -  - quceteinqucetein 61.7461.74 -  - 10.05 10.05 1.07 1.07 ruteorinruteorin 62.4462.44 102.26 102.26 -  - -  - hesperetinhesperetin 65.4865.48 4.61 4.61 12,720.80 12,720.80 0.27 0.27 dexamethasonedexamethasone 66.1566.15 56.77 56.77 -  - 32.53 32.53 alizarinalizarin 69.2569.25 10.78 10.78 49.90 49.90 129.05 129.05 rheinrhein 70.4070.40 1,134.04 1,134.04 -  - 182.01 182.01 Total amounts Total amounts 13,630.3913,630.39 32,656.2632,656.26 1,186.71,186.7

1) Not detected 1) Not detected

총 20종의 표준물질과 retention time이 일치하는 peak의 면적비를 이용하여 발효 쑥 또는 발효 솔잎 추출물, 산야초 발효액의 페놀성 화합물의 함량을 측정하였다. The content of phenolic compounds in fermented mugwort or fermented pine needle extract and wild vinegar fermentation broth was measured using the area ratio of peaks corresponding to retention time of 20 standard materials.

총 페놀 함량의 결과에서와 같이 개별 페놀성 화합물의 총량은 발효 쑥 추출물 (32,656 ug/g) > 발효 솔잎 추출물 (13,631 ug/g) > 산야초 발효액 (1,186 ug/g) 순으로 나타났으며, 비교 제조예인 산야초 발효액에 비해, 발효 솔잎 추출물에는 이들 페놀성 화합물의 함량이 약 11.5배 정도의 높은 함량을 보였고, 발효 쑥 추출물의 경우에도 약 27.5배 정도의 높은 함량을 나타내었다. As a result of the total phenolic content, the total amount of individual phenolic compounds was found in the order of fermented mugwort extract (32,656 ug / g)> fermented pine needle extract (13,631 ug / g)> wild vinegar fermentation broth (1,186 ug / g). Compared to the preparation of Sanyacho fermentation broth, the content of these phenolic compounds was about 11.5 times higher in the fermented pine needle extract, and about 27.5 times higher in the case of fermented mugwort extract.

또한, 비교 제조예의 산야초 발효액의 경우에는 pyrogallol, catechin, alizarin, 및 rhein이 주요한 페놀성 화합물로 분석된 반면, 제조예 1의 발효 솔잎 추출물에는 chlorogenic acid, rutin, rhein, p-comaric acid, p-anisic acid이 주요한 페놀성 화합물로 분석되었다. 한편, 페놀성 화합물의 총량이 가장 높았던 제조예 2의 발효 쑥 추출물은 hesperetin, rutin, vanillic acid, pyrogallol, 4-hydroxyl benehydrazid의 함량이 높게 나타나 발효 솔잎 추출물과는 다른 양상을 보였다.In addition, pyrogallol, catechin, alizarin, and rhein were analyzed as major phenolic compounds in the fermented broth of the comparative preparation, whereas chlorogenic acid, rutin, rhein, p-comaric acid, p- Anisic acid was analyzed as a major phenolic compound. On the other hand, the fermented mugwort extract of Preparation Example 2, which had the highest total amount of phenolic compounds, had a high content of hesperetin, rutin, vanillic acid, pyrogallol, and 4-hydroxyl benehydrazid, which was different from fermented pine needle extract.

이상 종합하면, 제조예 1, 2의 발효 솔잎 추출물, 발효 쑥 추출물은 비교 제조예의 산야초 발효액에 비하여 총 페놀 및 총 플라보노이드 함량이 매우 높음을 알 수 있었다.
In summary, it was found that the fermented pine needle extract and the fermented mugwort extract of Preparation Examples 1 and 2 had a very high total phenol and total flavonoid content as compared to the wild vegetable fermentation broth of Comparative Preparation Example.

실험예Experimental Example 4 : 발효 쑥, 발효 솔잎 추출물의 항산화 활성 4: Antioxidant Activity of Fermented Mugwort and Fermented Pine Needle Extracts

< 전자공여능 측정 (DPPH 라디칼 소거능 측정) ><Electron donating ability measurement (DPPH radical scavenging activity measurement)>

각 시료를 0.1 mg/mL, 0.5 mg/mL 농도로 제작하였다. 농도별로 나눈 시료를 0.2 mL 과 0.0004 M DPPH 시약 0.8 mL을 15 mL 튜브에 첨가하여 상온에서 10분간 방치하였다. 그 후 96-well plate에 200 ㎕씩 옮겨서 흡광도 517 nm에서 측정하였다. Each sample was prepared at a concentration of 0.1 mg / mL and 0.5 mg / mL. The sample divided by concentration was added to 0.2 mL and 0.8 mL of 0.0004 M DPPH reagent in a 15 mL tube and allowed to stand at room temperature for 10 minutes. Thereafter, 200 μl was transferred to a 96-well plate and the absorbance was measured at 517 nm.

그 결과는 도 14에 나타내었는데, 발효 쑥 추출물, 발효 혼합 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w), 발효 솔잎 추출물은 산야초 발효액에 비하여 항산화 효과가 매우 높은 것으로 나타났다.
The results are shown in Figure 14, fermented mugwort extract, fermented mixed extract (fermented pine needles: fermented mugwort = 1: 1, w / w), the fermented pine needle extract was found to have a very high antioxidant effect compared to the fermentation of wild grass.

< ABTS 라디칼 소거능 측정 ><Determination of ABTS radical scavenging activity>

각 시료를 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL 농도로 제작하였다. 7 mM ABTS와 2.45 mM Potassium persulfate를 1:0.5 비율로 섞은 혼합용액을 상온에서 16시간 incubation하였다. 이 혼합용액 1 mL과 무수에탄올 88 mL을 섞은 ABTS용액을 조제하였다. ABTS용액 1 mL과 시료 10 L를 1.5 mL tube에 넣고 6분간 반응시켰다. 그 후 96-well plate에 200 ㎕씩 옮겨서 흡광도 734 nm에서 측정하였다. Each sample was prepared at concentrations of 0.1 mg / mL, 0.5 mg / mL, and 1 mg / mL. A mixed solution of 7 mM ABTS and 2.45 mM Potassium persulfate in a 1: 0.5 ratio was incubated at room temperature for 16 hours. An ABTS solution containing 1 mL of this mixed solution and 88 mL of anhydrous ethanol was prepared. 1 mL of ABTS solution and 10 L of sample were added to a 1.5 mL tube and allowed to react for 6 minutes. Thereafter, 200 μl was transferred to a 96-well plate and the absorbance was measured at 734 nm.

그 결과는 도 15에 나타내었는데, 발효 쑥 추출물, 혼합 발효 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w), 발효 솔잎 추출물은 산야초 발효액에 비하여 항산화 효과가 매우 높은 것으로 나타났다.
The results are shown in Figure 15, fermented mugwort extract, mixed fermented extract (fermented pine needles: fermented mugwort = 1: 1, w / w), the fermented pine needle extract was found to have a very high antioxidant effect compared to wild vinegar fermentation broth.

< FRAP 활성 측정 ><FRAP activity measurement>

각 시료를 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL 농도로 제작하였다. 300 mM sodium acetate buffer와 10 mM TPTZ, 20 mM FeCl3?6H2O를 10:1:1로 혼합한 FRAP용액을 제조하여 2 mL tube에 FRAP용액 1.9 mL과 시료 100 ㎕를 넣고 37℃에서 30분간 반응시켰다. 그 후 96-well plate에 200 ㎕씩 옮겨서 흡광도 590 nm에서 측정하였다. Each sample was prepared at concentrations of 0.1 mg / mL, 0.5 mg / mL, and 1 mg / mL. Prepare a FRAP solution mixed with 300 mM sodium acetate buffer, 10 mM TPTZ, and 20 mM FeCl 3 ˜6H 2 O in a 10: 1: 1 mixture, add 1.9 mL of FRAP solution and 100 μl of sample to a 2 mL tube. The reaction was carried out for a minute. Thereafter, 200 μl was transferred to a 96-well plate and the absorbance was measured at 590 nm.

그 결과는 도 16에 나타내었는데, 발효 쑥 추출물, 혼합 발효 추출물(발효 솔잎 : 발효 쑥 = 1 : 1, w/w), 발효 솔잎 추출물은 산야초 발효액에 비하여 FRAP 활성이 매우 높은 것으로 나타났다.
The results are shown in Figure 16, the fermented mugwort extract, mixed fermented extract (fermented pine needles: fermented mugwort = 1: 1, w / w), the fermented pine needle extract was found to have a very high FRAP activity compared to wild vegetable fermentation broth.

< 환원력 측정 (Reducing power) ><Reducing power>

각 시료를 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL 농도로 제작하였다. 농도별로 나눈 시료 0.5 mL과 0.2 M Sodium phosphate buffer solution 2.5 mL, 1% Potassium ferricyanide 2.5 mL을 50 mL tube에 모두 넣은 후 50에서 20분간 incubation하였다. 그 후, 혼합물에 10% trichloroacetic acid 2.5 mL을 섞어주어 10분간 원심분리 하였다. 상층액 2.5 mL을 취하여 3차 증류수 2.5 mL과 0.1% Iron(Ⅲ) Chloride 0.5 mL을 혼합하여 96-well plate에 200 ㎕씩 옮겨서 흡광도 655 nm에서 측정하였다. Each sample was prepared at concentrations of 0.1 mg / mL, 0.5 mg / mL, and 1 mg / mL. 0.5 mL of the sample divided by concentration, 2.5 mL of 0.2 M sodium phosphate buffer solution and 2.5 mL of 1% Potassium ferricyanide were added to a 50 mL tube, followed by incubation for 50 to 20 minutes. Thereafter, 2.5 mL of 10% trichloroacetic acid was added to the mixture and centrifuged for 10 minutes. 2.5 mL of the supernatant was taken, and 2.5 mL of tertiary distilled water and 0.5 mL of 0.1% Iron (III) Chloride were mixed, and 200 μl of each of the 96-well plates was measured at an absorbance of 655 nm.

그 결과는 도 17에 나타내었는데, 발효 쑥 추출물, 혼합 발효 추출물, 발효 솔잎 추출물은 산야초 발효액에 비하여 항산화 효과가 매우 높은 것으로 나타났다.
The results are shown in Figure 17, the fermented mugwort extract, mixed fermented extract, the fermented pine needle extract was found to have a very high antioxidant effect compared to the wild vegetable fermentation.

실험예Experimental Example 5 : 발효 쑥 및 발효 솔잎 추출물의 세포 독성 평가 5: Evaluation of Cytotoxicity of Fermented Mugwort and Fermented Pine Needle Extracts

3T3-L1에 대한 시료의 세포독성평가는 XTT assay kit를 이용하여 측정하였다.Cytotoxicity evaluation of the sample for 3T3-L1 was measured using the XTT assay kit.

XTT에 election coupling agent 역할을 하는 PMS (phenazine methosulfate)를 첨가하여 bioreduction을 증가시키게 한 후, 세포에 XTT와 PMS를 첨가하여 살아있는 세포의 mitochondrial dehydrogenase에 의한 XTT의 tetrazolium ring을 분해시켜 formazan crystal을 형성하게 되면, formazan crystal은 수용액에 녹아 노란색을 나타나게 되는데 이 노란색을 ELISA(VersaMax ELISA Microplate Reader, Molecular Devices, Sunnyvale, USA)로 측정하여 세포 독성 평가에 이용하였다. 450 nm 흡광도 값에서 690 nm의 흡광도 값을 뺀 결과 값으로 세포독성을 계산하였다.Increase bioreduction by adding PMS (phenazine methosulfate) that acts as an election coupling agent to XTT, and then add XTT and PMS to cells to decompose the tetrazolium ring of XTT by mitochondrial dehydrogenase in living cells to form formazan crystal When the formazan crystal is dissolved in an aqueous solution, yellow color is obtained. The yellow color was measured by ELISA (VersaMax ELISA Microplate Reader, Molecular Devices, Sunnyvale, USA) and used for evaluation of cytotoxicity. The cytotoxicity was calculated by subtracting the absorbance value of 690 nm from the 450 nm absorbance value.

그 결과는 도 18에 나타내었는데, 500 ㎍/mL 농도까지는 대조군에 비하여 세포 독성을 미치지 않는 것으로 나타나 하기의 지방세포 분화 및 세포 내 지방축적에 대한 시료의 효능평가는 500 ㎍/mL 농도에서 시행하였다.
The results are shown in Figure 18, the concentration of 500 ㎍ / mL does not appear to be cytotoxic compared to the control group, the efficacy evaluation of the sample for the adipocyte differentiation and intracellular fat accumulation of the following was carried out at 500 ㎍ / mL concentration .

실험예Experimental Example 6 : 세포주를 이용한 대사증후군 관련(지방축적 억제 및 활성산소  6: Metabolic syndrome using cell lines (fat accumulation inhibition and free radicals 저감Abatement ) 효능검증 Efficacy Verification

본 실험에 사용된 시료는 DMSO(dimethyl sulfoxide)에 녹인 후, 3T3-L1 세포독성 및 지방세포 분화 실험에 사용하였다. The samples used in this experiment were dissolved in DMSO (dimethyl sulfoxide) and used for 3T3-L1 cytotoxicity and adipocyte differentiation experiments.

3T3-L1 세포주는 American Type Culture Collection (ATCC, CL-173, Manassas, VA, USA)으로부터 분양받아 사용하였으며, 3T3-L1 세포배양 및 분화에 사용된 insulin, Oil Red O, Dexamethasone (DEX), 3-isobutyl-1-methylxanthine (IBMX)은 Sigma (Sigma-Aldrich Co., St. Louis, MO, USA)로부터 구입하였고, Dulbecco's modified Eagle's medium (DMEM), bovine serum (BS), fetal bovine serum (FBS), penicillin-streptomycin (P/S), phosphate-buffered saline (PBS) 및 trypsin-EDTA는 Gibco (Gaithersburg, MD, USA)로부터 구입하여 사용하였다. The 3T3-L1 cell line was used from the American Type Culture Collection (ATCC, CL-173, Manassas, VA, USA) and used for insulin, Oil Red O, Dexamethasone (DEX), 3 used for 3T3-L1 cell culture and differentiation. -isobutyl-1-methylxanthine (IBMX) was purchased from Sigma (Sigma-Aldrich Co., St. Louis, MO, USA), Dulbecco's modified Eagle's medium (DMEM), bovine serum (BS), fetal bovine serum (FBS) , penicillin-streptomycin (P / S), phosphate-buffered saline (PBS) and trypsin-EDTA were purchased from Gibco (Gaithersburg, MD, USA).

3T3-L1 전구지방세포는 실험목적에 따라 24-well 및 96-well에 각각 1×06 seeding한 후, BS(10%) 및 P/S(1%)를 함유한 고농도 포도당 DMEM (89%)에서 100% confluence될 때까지 배양하였다. 이로부터 2일 후에, 지방세포 분화유도 물질 (10 ㎍/mL insulin, 1 μM DEX, 0.5 mM IBMX)과 FBS (10%) 및 P/S (10%)를 함유한 DMEM으로 전지방세포를 지방세포로 분화유도 하였으며, 지방세포 분화 (day 0)시 DMEM에 시료를 독성 평가 결과에 따라 500 ㎍/mL로 처리하여 지방세포의 분화억제 효과 및 세포 내 지방축적의 변화를 관찰하였다.3T3-L1 precursor cells were seeded at 1 × 0 6 in 24-well and 96-well, respectively, according to the experimental purpose, and then concentrated glucose DMEM (89%) containing BS (10%) and P / S (1%). Incubated until 100% confluence. Two days later, all cells were adipated with DMEM containing adipocyte differentiation-inducing substance (10 μg / mL insulin, 1 μM DEX, 0.5 mM IBMX) and FBS (10%) and P / S (10%). Differentiation was induced into cells, and when adipocyte differentiation (day 0), the samples were treated with DMEM at 500 ㎍ / mL according to the results of toxicity evaluation.

지방세포의 분화는 분화유도 물질을 처리한 후, 2일마다 지속적으로 10 ㎍/mL insulin, 1% P/S, 10% FBS가 함유된 배지에 각각의 시료를 처리한 후, 8일 동안 분화시키면서 지방축적량 및 ROS의 생성량을 관찰하였다.The differentiation of adipocytes was differentiated for 8 days after treatment with differentiation-inducing substances, each sample was treated with medium containing 10 μg / mL insulin, 1% P / S and 10% FBS every 2 days. Fat accumulation and ROS production were observed.

< Oil red O staining을 통한 지방 축적량 관찰 ><Observation of fat accumulation by Oil red O staining>

분화과정에 따른 3T3-L1 세포내 지방축적량을 측정하고자 각각의 시료를 처리하여 24-well에서 8일 동안 분화된 3T3-L1 세포의 배양액을 제거한 후, 10% formalin 용액 500 ㎕를 첨가하여 5분간 실온에서 방치하였다. 동량의 formalin 용액으로 분화된 3T3-L1 세포를 1시간 이상 실온에서 방치한 후, formalin을 제거하고 60% isopropanol 용액 500 ㎕로 세척하여 세포를 완전히 건조시켰다. 완전히 건조된 세포들은 미리 제조해 둔 Oil red O working solution (Oil red O : DDW = 6 : 4)으로 세포 내 축적된 지방성분들을 충분히 염색하였고, 증류수를 이용하여 세포를 3-4회 세척하고 다시 완전히 건조시켰다. 세포 내 축적된 지방성분과 결합한 Oil red O는 100% isopropanol을 이용하여 모두 용출시킨 후, ELISA를 이용하여 490 nm에서 흡광도를 측정하였다.In order to determine the amount of 3T3-L1 intracellular fat accumulation according to the differentiation process, each sample was treated to remove culture medium of differentiated 3T3-L1 cells for 8 days in 24-well, and then 500 μl of 10% formalin solution was added for 5 minutes. It was left at room temperature. After 3T3-L1 cells differentiated with the same amount of formalin solution was left at room temperature for at least 1 hour, formalin was removed and washed with 500 µl of 60% isopropanol solution to completely dry the cells. Completely dried cells were sufficiently stained fat components accumulated in the cells with a pre-prepared Oil red O working solution (Oil red O: DDW = 6: 4), washed the cells 3-4 times with distilled water and again It was dried completely. Oil red O bound to the fat component accumulated in cells was eluted with 100% isopropanol, and then absorbance was measured at 490 nm using ELISA.

그 결과는 도 19에 나타내었는데, 발효 솔잎 추출물과 혼합 발효 추출물에서 지방 축적을 억제하는 효과가 탁월함을 알 수 있었다.
The results are shown in Figure 19, it was found that the effect of inhibiting fat accumulation in fermented pine needle extract and mixed fermentation extract is excellent.

< NBT assay를 통한 ROS 측정량 측정 ><ROS measurement by NBT assay>

분화과정에 따른 지방세포의 ROS 생성량을 측정하기 위하여 먼저 24-well에 배양 및 분화된 3T3-L1 세포의 배양액을 제거한 후 멸균된 PBS(Phosphate buffer saline, pH 7.4)를 이용하여 2회 세척, 0.2% NBT 용액 0.2 mL를 첨가하여 CO2 incubator안에서 90분간 반응시켰다. 지방세포 내에 축적된 ROS는 NBT 용액과 반응하여 dark blue formazan을 생성하게 되며, 100% acetic acid를 이용하여 이들 dark blue formazan을 모두 용출시켜 570 nm에서 흡광도를 측정하였다.In order to measure the ROS production of adipocytes according to differentiation process, first remove the culture solution of 3T3-L1 cells cultured and differentiated in 24-well, and then wash twice with sterilized PBS (Phosphate buffer saline, pH 7.4), 0.2 0.2 mL of% NBT solution was added and reacted for 90 minutes in a CO 2 incubator. ROS accumulated in adipocytes reacted with NBT solution to produce dark blue formazan, and the absorbance was measured at 570 nm by eluting all of these dark blue formazan using 100% acetic acid.

그 결과는 도 20에 나타내었는데, 발효 솔잎 추출물, 혼합 발효 추출물에서 ROS 생성 억제 효과가 탁월함을 알 수 있었다.
The results are shown in Figure 20, it was found that the effect of inhibiting the ROS production in fermented pine needle extract, mixed fermentation extract.

< 주요 유전자의 발현 조사 ><Expression of major genes>

지방세포에서 분화에 관여하는 주요 유전자들의 변화를 검토하기 위하여 지방세포에 존재하는 total RNA를 추출한 후, 역전사중합효소(reverse transcriptase)를 사용하여 cDNA를 만들었다. 합성된 cDNA와 각각의 유전자별 primer를 RT-PCR로 증폭한 후 유전자의 발현정도를 측정하였다. To examine the changes in major genes involved in differentiation in adipocytes, total RNA in adipocytes was extracted, and cDNA was prepared using reverse transcriptase. Synthesized cDNA and primers for each gene were amplified by RT-PCR and the expression levels of the genes were measured.

- Total RNA의 추출 및 cDNA의 합성 : 지방세포로부터 total RNA의 추출은 TRIzol reagent (phenol + guanidine isothiocyanate) 방법을 이용하였다. 분화 8일째 되는 지방세포에 PBS를 이용하여 2회 세척하고 1 mL의 TRIzol을 첨가하여 세포들을 수확하였다. 1 mL의 TRIzol reagent당 0.2 mL의 chloroform을 넣고 15초간 잘 흔들어 준 후 실온에서 2-3분간 반응시키고 15,000 rpm에서 10분간 원심분리한 후 상등액을 걷어내어 다른 튜브에 옮기고 isopropyl alcohol (최초에 사용된 TRIzol 1 mL당 0.5 mL)을 넣고 10분간 반응시켜 RNA를 침전시켰다. 침전된 RNA에 70% DEPC-ethanol로 씻어준 후 (최초에 사용된 TRIzol 1 mL당 1 mL) 11,000 rpm에서 약 5분간 원심분리 하고 실온에서 pellet을 5-10분간 건조시킨 다음 DEPC water 40 ㎕에 녹여서 spectrophotometer(260 nm)로 O.D.값을 측정하여 total RNA의 농도를 정량하였다. cDNA Premix (Maxime RT Premix (oligo dT primer), Seongnam, South Korea)에 동일한 농도의 total RNA를 각각 5 ㎍씩 넣고 전체 용량이 20 ㎕가 되도록 DEPC-water를 첨가한 후, 45℃에서 60분간, 95℃에서 5분간 처리하여 cDNA를 합성하였다. -Extraction of Total RNA and Synthesis of cDNA: Total RNA was extracted from adipocytes using TRIzol reagent (phenol + guanidine isothiocyanate). Adipocytes at 8 days of differentiation were washed twice with PBS and 1 mL of TRIzol was added to harvest the cells. Add 0.2 mL of chloroform per 1 mL of TRIzol reagent, shake well for 15 seconds, react for 2-3 minutes at room temperature, centrifuge at 15,000 rpm for 10 minutes, remove the supernatant, transfer to another tube, and use isopropyl alcohol (first used 0.5 mL per 1 mL of TRIzol) was added and allowed to react for 10 minutes to precipitate RNA. After washing the precipitated RNA with 70% DEPC-ethanol (1 mL per 1 mL of the first TRIzol used), centrifuge at 11,000 rpm for about 5 minutes, dry the pellet at room temperature for 5-10 minutes, and 40 mL of DEPC water. The total RNA concentration was quantified by measuring the OD value with a spectrophotometer (260 nm). 5 μg of total RNA of the same concentration was added to cDNA Premix (Maxime RT Premix (oligo dT primer), Seongnam, South Korea), and DEPC-water was added so that the total volume was 20 μl. CDNA was synthesized by treatment at 95 ° C. for 5 minutes.

- Semi-quantitative RT-PCR : cDNA와 지방세포 분화와 관련된 주요 유전자 (표 2)의 primer들을 각각 혼합한 후, RT-PCR Amplification mixture를 혼합하여 전체 부피가 12 ㎕가 되도록 하여, denaturation, annealing, polymerization 단계를 35회 반복하면서 원하는 DNA 부분을 증폭시켰다. 이때 annealing 온도는 primer에 따라 각각 적정온도로 처리하였다. RT-PCR 산물을 확인하기 위하여 5 ㎕를 취하여 1.5% 한천(agarose) 겔에서 전기영동한 후, EtBr (ethidium bromide)로 염색하여 자외선투시기(transilluminator)를 이용하여 증폭된 DNA band를 확인하였다. DNA band는 Carestream MI SE 프로그램을 이용하여 band intensity로 수치화하여 나타내었다. -Semi-quantitative RT-PCR: After mixing primers of major genes related to cDNA and adipocyte differentiation (Table 2), RT-PCR amplification mixture was mixed to make 12 μl total volume, denaturation, annealing, The polymerization was repeated 35 times to amplify the desired DNA portion. At this time, the annealing temperature was treated at the appropriate temperature according to the primer. To confirm the RT-PCR product, 5 μl was taken and electrophoresed on a 1.5% agar (agarose) gel, followed by staining with EtBr (ethidium bromide) to confirm the amplified DNA band using a transilluminator. DNA bands were expressed by band intensity using Carestream MI SE program.

Figure 112012062012963-pat00001
Figure 112012062012963-pat00001

그 결과는 도 21에 나타내었는데, 지방생성 관련 유전자인 PPAR 와 aP2의 발현 정도를 확인한 결과, 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물을 처리한 세포에서 기존 산야초 발효액보다 지방 생성을 많이 억제하며, 특히 발효 솔잎 추출물 및 혼합 발효 추출물에서 탁월하게 억제하는 것으로 나타났다. The results are shown in Figure 21, as a result of confirming the expression level of PPAR and aP2 genes related to the production of fat, the cells treated with the fermented mugwort extract, fermented pine needle extract and mixed fermented extract inhibits fat production more than conventional wild vegetable fermentation broth. , Especially in fermented pine needle extract and mixed fermented extract.

또한, ROS생성과 연관된 NOX4의 경우에는 상기 NBT assay 결과와 비슷한 경향을 보였으며, 항산화효소인 Cu/Zn SOD의 경우에도 기존 산야초 발효액보다 본 발명의 발효 쑥 추출물, 발효 솔잎 추출물 및 혼합 발효 추출물에서 발현이 강하게 나타남을 알 수 있었다. In addition, in the case of NOX4 associated with ROS production showed a similar tendency to the NBT assay results, even in the case of the antioxidant enzyme Cu / Zn SOD in the fermented mugwort extract, fermented pine needle extract and mixed fermentation extract of the present invention than conventional wild vegetable It can be seen that the expression is strong.

한편, 3T3-L1 지방세포의 분화 억제 효능은 총 페놀, 총 플라보노이드 및 항산화 활성의 결과와는 달리 발효 솔잎 추출물에서 가장 높은 억제효과를 나타내었다. 이는 발효 솔잎에 함유된 특정 페놀성 화합물이 in vitro 항산화 활성에는 별다른 활성을 나타내지 않는 반면, 3T3-L1 지방세포 분화에 대한 특이적 억제효능을 갖는 것을 알 수 있었다.
On the other hand, the inhibition of differentiation of 3T3-L1 adipocytes showed the highest inhibitory effect in fermented pine needle extract, unlike the results of total phenol, total flavonoid and antioxidant activity. This is a particular phenolic compound contained in the fermentation pine needle in In vitro antioxidant activity was not shown, while it was found to have a specific inhibitory effect on 3T3-L1 adipocyte differentiation.

실험예Experimental Example 7 : 발효 솔잎, 발효 쑥 추출물의 관능평가 7: Sensory Evaluation of Fermented Pine Needles and Fermented Mugwort Extracts

발효 쑥 및 발효 솔잎의 묘사시험을 실시하여 발효취, 쓴맛, 떫은맛, 단맛, 기호도의 관능적 특성들을 선정하였다. 제시된 관능적 특성에 대하여 훈련된 관능 검사요원(10명)을 대상으로 비교 제조예의 산야초 발효액을 5점 만점으로 하여 제조예 1, 2의 발효 솔잎 및 발효 쑥 추출물에 대한 모든 관능적 특성들을 9점 척도법으로 비교, 평가하였다.Descriptive tests of fermented mugwort and fermented pine needles were carried out to select the sensory characteristics of fermented odor, bitter taste, astringent taste, sweetness and preference. All sensory characteristics of fermented pine needles and fermented mugwort extracts of Preparation Examples 1 and 2 were scored on a nine-point scale using 10 of the sensory test personnel trained on the proposed sensory characteristics. Compare and evaluate.

그 결과는 도 22에 나타내었는데, 제조예 1, 2의 발효 솔잎, 발효 쑥 추출물은 비교 제조예의 산야초 발효액에 비하여 발효취, 쓴맛, 떫은맛, 단맛이 감소된 반면 기호도는 증가함을 알 수 있었다. 이에 의하면 비교 제조예의 산야초 발효액은 지나치게 달고, 쓰고 떫은 맛이 강하나, 제조예 1, 2의 발효 솔잎, 발효 쑥 추출물은 지나친 단맛, 쓴맛, 떫은 맛이 중화되면서 기호도가 증가함을 알 수 있었다. The results are shown in Figure 22, the fermented pine needles, fermented mugwort extracts of Preparation Examples 1 and 2 was found that the fermentation odor, bitter taste, astringent taste, sweet taste was reduced compared to the wild vinegar fermentation solution of Comparative Preparation Example, while the palatability increased. According to this, it was found that the fermented broth of Sanyacho of the Comparative Preparation Example was too sweet and had a bitter astringent taste, but the fermented pine needles and Fermented Wormwood Extracts of Preparation Examples 1 and 2 increased their palatability while neutralizing excessive sweetness, bitterness and astringency.

Claims (4)

쑥 또는 솔잎 중 하나 이상의 추출물에 젖산균을 접종하여 발효시키는 것을 특징으로 발효 약초 추출물의 제조방법.
Method of producing a fermented herbal extract characterized in that the fermentation by inoculating lactic acid bacteria into one or more extracts of mugwort or pine needles.
제1항에 있어서,
상기 젖산균은 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 1076인 것을 특징으로 하는 발효 약초 추출물의 제조방법.
The method of claim 1,
The lactic acid bacteria is Leuconostoc Leukonostoc mesenteroides ) 1076 method for producing a fermented herb extract, characterized in that.
제1항 또는 제2항에 있어서,
상기 쑥 또는 솔잎 중 하나 이상의 추출물은
쑥 또는 솔잎 중 하나 이상을 분쇄한 후, 증류수를 가하여 24 ~ 26℃에서 23 ~ 25시간 동안 추출한 것을 특징으로 하는 발효 약초 추출물의 제조방법.
The method according to claim 1 or 2,
Extract of one or more of the wormwood or pine needles
After pulverizing at least one of the wormwood or pine needles, the method of producing a fermented herbal extract characterized in that the extract for 23 to 25 hours at 24 ~ 26 ℃ by adding distilled water.
제1항 또는 제2항에 있어서,
상기 발효는 190 ~ 210 rpm으로 29 ~ 31℃에서 35 ~ 37 시간 동안 수행되는 것을 특징으로 하는 발효 약초 추출물의 제조방법.
The method according to claim 1 or 2,
The fermentation is a method for producing a fermented herb extract, characterized in that carried out for 35 to 37 hours at 29 ~ 31 ℃ at 190 ~ 210 rpm.
KR1020120084841A 2012-08-02 2012-08-02 Producing method for fermented wild grass extracts with biological activity KR101203096B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120084841A KR101203096B1 (en) 2012-08-02 2012-08-02 Producing method for fermented wild grass extracts with biological activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120084841A KR101203096B1 (en) 2012-08-02 2012-08-02 Producing method for fermented wild grass extracts with biological activity

Publications (1)

Publication Number Publication Date
KR101203096B1 true KR101203096B1 (en) 2012-11-21

Family

ID=47565032

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120084841A KR101203096B1 (en) 2012-08-02 2012-08-02 Producing method for fermented wild grass extracts with biological activity

Country Status (1)

Country Link
KR (1) KR101203096B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323694B1 (en) * 2013-04-10 2013-10-30 박사천 Geomundo sea breeze mugwort liquid tea and its manufacturing method
KR101824610B1 (en) * 2016-09-13 2018-02-01 주식회사 화진바이오코스메틱 Method for producing Fermented wild ginseng adventitious root with enhanced specific phenolic compounds content

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323694B1 (en) * 2013-04-10 2013-10-30 박사천 Geomundo sea breeze mugwort liquid tea and its manufacturing method
KR101824610B1 (en) * 2016-09-13 2018-02-01 주식회사 화진바이오코스메틱 Method for producing Fermented wild ginseng adventitious root with enhanced specific phenolic compounds content

Similar Documents

Publication Publication Date Title
KR102386296B1 (en) Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof
CN110731436B (en) Black tiger acetic acid beverage as well as preparation method and application thereof
KR101678560B1 (en) Beverage Containing Purple Corn Cob Extract and Method for Preparing Thereof
KR101203096B1 (en) Producing method for fermented wild grass extracts with biological activity
KR100755515B1 (en) Functional drinks using Salicornia herbacea and a method of manufacturing process
KR20180094208A (en) Preparing method of fermentative metabolites from stachys sieboldii having imrpoving cognitive fuctions
Hlahla Effect of fermentation temperature and duration on chemical composition of Bush tea (Athrixia phylicoides DC.)
KR101091833B1 (en) Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria
KR101438717B1 (en) Composition of the fermented extract of plants with dandelion for protection of hepatic functions
KR101429828B1 (en) Functional health drink using fermented vinegar comprising dropwort
GHOSH et al. Comparative phytochemical analysis of mature mango leaves from nineteen cultivars of Murshidabad district, India
Chanhan et al. Effect of agricultural model of using fertilizer, harvesting time and extraction method on phytochemical contents and antioxidant activities from mulberry leaves grown in Maha Sarakham Province, Thailand
KR102464052B1 (en) Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof
KR20160060834A (en) Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same
KR102298700B1 (en) Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg
KR20130017431A (en) An antioxidantive composition of persimmom wine powder using monascus purpureus spp. strain
KR101399398B1 (en) Method for manufacturing submerged-state fermented Allium victorialis and Composition for preventing or treating anti-diabetes or anti-diabetic complication containing fermented Allium victorialis
KR20160058201A (en) Manufacturing method of ginseng leaves powder cultured by hydroponics and ginseng leaves powder thereof
KR102416743B1 (en) Composition comprising fermented germinating plant extract and preparation method thereof
KR101608271B1 (en) A strain of rhizopus stolonifer from fermented tea and uses thereof
KR101696342B1 (en) Composition for Anti-Diabetes
KR102454480B1 (en) Manufacturing method for snack composition using Cedrela sinensis and Cynanchum wilfordii
KR101498075B1 (en) Composition and health functional food containing extracts of sorghum bran
KR102281263B1 (en) Enzyme treated catechin product containing increased gallic acid, epicatechin and epigallocatechin content and preparation method thereof
KR102396816B1 (en) Cosmetic composition and cosmetic additive composition comprising extracted-fermented Glycyrrhizia uralensis leaf

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20151012

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160920

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20171019

Year of fee payment: 6